Awakn Life Sciences Announces the Findings from the Phase II A/B Study Are to Be Published in the American Journal of… Nov 4, 2021
MINDCURE Signs LOI with Awakn Life Sciences to Distribute Ketamine Protocol for Alcohol Use Disorder into Clinics Across… Oct 28, 2021
British MP Pushes For Rescheduling Of Psilocybin (Plus 3 Psychedelic PubCos Working In The UK) Oct 22, 2021
Awakn Life Sciences: Re-Imagining Novel Therapeutic Solutions For Substance Use Disorders Oct 15, 2021
Awakn Life Sciences Announces Closing of Acquisition of Leading Ketamine-Assisted Psychotherapy Clinic in Norway Oct 5, 2021
Ketamine: How An Anesthetic Came To Be Used As A Psychedelic Treatment (And 5 PubCo’s Focused On It) Sep 23, 2021
Awakn Life Sciences Reports Second Quarter 2021 Financial Results and Business Highlights Sep 15, 2021
